Kavya Pharma

Cinacalcet

CAS : 226256-56-0

Chemical formula : C22H22F3N

For the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease who are on hemodialysis or peritoneal dialysis. Also for the treatment of hypercalcemia in patients with parathyroid carcinoma.

The calcium-sensing receptors on the surface of the chief cell of the parathyroid gland is the principal regulator of parathyroid hormone secretion (PTH). Cinacalcet directly lowers parathyroid hormone levels by increasing the sensitivity of the calcium sensing receptors to activation by extracellular calcium, resulting in the inhibition of PTH secretion. The reduction in PTH is associated with a concomitant decrease in serum calcium levels.

  • Finasteride ip
  • Desonide ip
  • Lycopene
  • Promethazine ip
  • Rosiglitazone Maleate USP
  • Tenofovir Disoproxil Fumarate
  • Lamivudine
  • Rivaroxaban
  • Apixaban
  • Solifenacin Succinate
  • Zafirlukast HIS
  • Flxofenadine HCI USP
  • Carvedilol USP
  • Sparfloxacin HIS
  • lrbesartan USP
  • Olmesartan Medoxomil USP
  • Losartan Potassium lP
  • Amlodipine Besylate
  • Ketoconazole EPlUSP